The yin and yang of tumor necrosis factor inhibitors

被引：16

作者：

Calabrese, L

机构：

[1] Cleveland Clin Fdn, Clin Immunol Sect, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA

[3] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2006年 / 73卷 / 03期

关键词：

D O I：

10.3949/ccjm.73.3.251

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tumor necrosis factor (TNF) inhibitors have proven highly effective against a number of autoimmune diseases but have been disappointing in treating others. An increase in the risk of Mycobacterium tuberculosis and other opportunistic infections has been noted in patients treated with these agents. If we use these drugs, we need to weigh their beneficial and adverse effects.

引用

页码：251 / 256

页数：6

共 30 条

[11] INCIDENCE OF CANCER AMONG PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

GRIDLEY, G ;

MCLAUGHLIN, JK ;

EKBOM, A ;

KLARESKOG, L ;

ADAMI, HO ;

HACKER, DG ;

HOOVER, R ;

FRAUMENI, JF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04) :307-311

[12] EXCESS RISK OF LYMPHOMAS, LEUKEMIA AND MYELOMA IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

ISOMAKI, HA ;

HAKULINEN, T ;

JOUTSENLAHTI, U .

JOURNAL OF CHRONIC DISEASES, 1978, 31 (11) :691-696

[13] Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept [J].

Lee, JH ;

Slifman, NR ;

Gershon, SK ;

Edwards, ET ;

Schwieterman, WD ;

Siegel, JN ;

Wise, RP ;

Brown, SL ;

Udall, JN ;

Braun, MM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2565-2570

[14]

MATTESON EL, 1991, J RHEUMATOL, V18, P809

[15] Rheumatoid arthritis and cancer risk [J].

Mellemkjaer, L ;

Linet, MS ;

Gridley, G ;

Frisch, M ;

Moller, H ;

Olsen, JH .

EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) :1753-1757

[16]

Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO

[17]

2-W

[18] Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology [J].

Mohan, VP ;

Scanga, CA ;

Yu, KM ;

Scott, HM ;

Tanaka, KE ;

Tsang, E ;

Tsai, MC ;

Flynn, JL ;

Chan, J .

INFECTION AND IMMUNITY, 2001, 69 (03) :1847-1855

[19] LOCATION OF TUMOR-NECROSIS-FACTOR-ALPHA BY IMMUNOHISTOCHEMISTRY IN CHRONIC INFLAMMATORY BOWEL-DISEASE [J].

MURCH, SH ;

BRAEGGER, CP ;

WALKERSMITH, JA ;

MACDONALD, TT .

GUT, 1993, 34 (12) :1705-1709

[20] MECHANISMS OF DISEASE Inflammatory Bowel Disease [J].

Abraham, Clara ;

Cho, Judy H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2066-2078

← 1 2 3 →